Myth-buster
A double-blind trial of 500 mg Haritaki twice daily for angina found no improvement in symptoms — and no effect on cholesterol, inflammation, or quality of life either.
This small but well-designed study contradicts the popular belief that Haritaki helps heart conditions, but since it's one of the first trials on this pairing, the verdict is far from final.
In a 180-day randomized controlled trial with 100 people, Haritaki (an Ayurvedic herb) failed to improve angina symptoms as measured by the Seattle Angina Questionnaire, which tracks chest pain and daily function. The study also checked cholesterol, inflammation, and exercise tolerance, and found no benefit on any of those outcomes. While the null results are consistent across all measured endpoints, the small sample size and novelty of the evidence mean more research is needed before drawing strong conclusions.
Where this fits in the evidence
This is among the first studies we've indexed on Haritaki for Improved Angina Symptom — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- n = 100
- 2026-01-24
- BMC complementary medicine and therapies
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.